BRILINTA 90MG TABLET

BRILINTA 90MG TABLET is a highly effective antiplatelet medication designed to prevent the formation of dangerous blood clots in patients at risk of cardiovascular events. Containing Ticagrelor, this pharmaceutical product is widely used to reduce the risk of heart attack, stroke, and other serious complications in patients with acute coronary syndromes or a history of cardiovascular diseases. Its advanced formulation ensures rapid action, providing reliable protection for heart health. It is also available in 60 mg tablet form.

The tablet works by inhibiting platelet aggregation, thereby maintaining smooth blood flow through the arteries and preventing blockage. BRILINTA 90MG is often prescribed alongside low-dose aspirin to maximize cardiovascular protection. Its oral administration and twice-daily dosage make it convenient for long-term management while ensuring consistent efficacy.

BRILINTA 90MG TABLET helps patients maintain a healthy cardiovascular system while minimizing the risk of adverse events. Regular use under medical supervision supports optimal heart function and overall well-being. Whether for secondary prevention after a heart attack or managing acute coronary syndrome, BRILINTA 90MG remains a cornerstone in cardiovascular therapy.

Product Features

• Contains ticagrelor—a potent antiplatelet agent
• Prevents blood clot formation in arteries
• Recommended for patients with acute coronary syndrome
• Convenient oral tablet with twice-daily dosage
• Works effectively alongside low-dose aspirin

How It Helps

• Reduces the risk of heart attack and stroke
• Prevents dangerous blood clot formation
• Supports optimal cardiovascular health
• Enhances the effectiveness of aspirin therapy